Hester Biosciences says on track to produce Covaxin drug substance by Q4FY22

Hester Biosciences says on track to produce Covaxin drug substance by Q4FY22

Hester Biosciences says on track to produce Covaxin drug substance by Q4FY22 The construction of a BSL-3 facility suitable for manufacturing the drug substance of Covaxin is underway. The vaccine maker intends to produce 5 million to 15 million doses of Covaxin drug substance.